[HTML][HTML] Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three …
D Ljolje, PR Dimbu, J Kelley, I Goldman, D Nace… - Malaria journal, 2018 - Springer
Background Artemisinin-based combination therapy is the first-line anti-malarial treatment
for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in …
D Ljolje, PR Dimbu, J Kelley, I Goldman, D Nace… - Malaria Journal, 2018 - go.gale.com
Background Artemisinin-based combination therapy is the first-line anti-malarial treatment
for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in …
D Ljolje, PR Dimbu, J Kelley, I Goldman… - Malaria …, 2018 - search.ebscohost.com
Background: Artemisinin-based combination therapy is the first-line anti-malarial treatment
for uncomplicated < italic> Plasmodium falciparum</italic> infection in Angola. To …
for uncomplicated < italic> Plasmodium falciparum</italic> infection in Angola. To …
Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in …
D Ljolje, PR Dimbu, J Kelley, I Goldman, D Nace… - Malaria …, 2018 - europepmc.org
Background Artemisinin-based combination therapy is the first-line anti-malarial treatment
for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
[HTML][HTML] Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three …
D Ljolje, PR Dimbu, J Kelley, I Goldman, D Nace… - Malaria …, 2018 - ncbi.nlm.nih.gov
Background Artemisinin-based combination therapy is the first-line anti-malarial treatment
for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in …
D Ljolje, PR Dimbu, J Kelley, I Goldman, D Nace… - 2018 - cabidigitallibrary.org
Background: Artemisinin-based combination therapy is the first-line anti-malarial treatment
for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in …
D Ljolje, PR Dimbu, J Kelley, I Goldman… - Malaria …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Artemisinin-based combination therapy is the first-line anti-malarial treatment
for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
[引用][C] Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three …
D Ljolje, PR Dimbu, J Kelley, I Goldman, D Nace… - Malaria Journal, 2018 - cir.nii.ac.jp
Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients
with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015 | CiNii …
with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015 | CiNii …
[HTML][HTML] Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three …
D Ljolje, PR Dimbu, J Kelley… - Malaria …, 2018 - malariajournal.biomedcentral.com
Artemisinin-based combination therapy is the first-line anti-malarial treatment for
uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in …
D Ljolje, PR Dimbu, J Kelley, I Goldman, D Nace… - Malaria …, 2018 - europepmc.org
Background Artemisinin-based combination therapy is the first-line anti-malarial treatment
for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …
for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of …